Approval · Notice of Compliance 839 · 2002
ANDRODERM: Notice of Compliance 839
Issued June 20, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 839
- Date
- June 20, 2002
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Adiition of a new strength
- Therapeutic class
- Testosterone replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANDRODERM | 02245972 | Cancelled Post Market |
Medicinal ingredients
- TESTOSTERONE 24.3 MG per PAD